Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.2 USD | +0.96% |
|
-20.00% | -72.28% |
06-20 | UBS Downgrades Zentalis Pharmaceuticals to Neutral From Buy, Adjusts Price Target to $5 From $28 | MT |
06-18 | US Equity Markets Close Up Tuesday Following Less-Than-Expected Retail Sales Growth | MT |
- Stock Market
- Equities
- ZNTL Stock
- News Zentalis Pharmaceuticals, Inc.
- MarketScreener Strategies